135 related articles for article (PubMed ID: 25313208)
1. Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin.
Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O
Antimicrob Agents Chemother; 2015 Jan; 59(1):53-8. PubMed ID: 25313208
[TBL] [Abstract][Full Text] [Related]
2. Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem.
Agudelo M; Rodriguez CA; Pelaez CA; Vesga O
Antimicrob Agents Chemother; 2014; 58(2):1005-18. PubMed ID: 24277034
[TBL] [Abstract][Full Text] [Related]
3. Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator.
Vesga O; Agudelo M; Salazar BE; Rodriguez CA; Zuluaga AF
Antimicrob Agents Chemother; 2010 Aug; 54(8):3271-9. PubMed ID: 20547818
[TBL] [Abstract][Full Text] [Related]
4. Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam.
Rodriguez CA; Agudelo M; Aguilar YA; Zuluaga AF; Vesga O
PLoS One; 2016; 11(5):e0155806. PubMed ID: 27191163
[TBL] [Abstract][Full Text] [Related]
5. Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin.
Agudelo M; Rodriguez CA; Zuluaga AF; Vesga O
PLoS One; 2019; 14(2):e0211096. PubMed ID: 30726248
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic equivalence requires pharmaceutical, pharmacokinetic, and pharmacodynamic identities: true bioequivalence of a generic product of intravenous metronidazole.
Agudelo M; Vesga O
Antimicrob Agents Chemother; 2012 May; 56(5):2659-65. PubMed ID: 22330928
[TBL] [Abstract][Full Text] [Related]
7. Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.
Zuluaga AF; Agudelo M; Cardeño JJ; Rodriguez CA; Vesga O
PLoS One; 2010 May; 5(5):e10744. PubMed ID: 20505762
[TBL] [Abstract][Full Text] [Related]
8. Comparison of In Vivo Pharmacokinetics and Pharmacodynamics of Vancomycin Products Available in Korea.
Kim HK; Choi SM; Kang G; Park KH; Lee DG; Park WB; Rhee SJ; Lee S; Jung SI; Jang HC
Yonsei Med J; 2020 Apr; 61(4):301-309. PubMed ID: 32233172
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products.
Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O
Int J Antimicrob Agents; 2017 Feb; 49(2):189-197. PubMed ID: 27988068
[TBL] [Abstract][Full Text] [Related]
10. Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam.
Agudelo M; Rodriguez CA; Zuluaga AF; Vesga O
Int J Antimicrob Agents; 2015 Feb; 45(2):161-7. PubMed ID: 25481459
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis.
Gonzalez JM; Rodriguez CA; Zuluaga AF; Agudelo M; Vesga O
PLoS One; 2015; 10(11):e0141872. PubMed ID: 26536105
[TBL] [Abstract][Full Text] [Related]
12. Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa.
Grégoire N; Raherison S; Grignon C; Comets E; Marliat M; Ploy MC; Couet W
Antimicrob Agents Chemother; 2010 Jun; 54(6):2379-84. PubMed ID: 20368392
[TBL] [Abstract][Full Text] [Related]
13. Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.
Rees VE; Yadav R; Rogers KE; Bulitta JB; Wirth V; Oliver A; Boyce JD; Peleg AY; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104278
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa: In Vitro and In Vivo Studies.
Hazlett LD; Ekanayaka SA; McClellan SA; Francis R
Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):2978-2989. PubMed ID: 31311033
[TBL] [Abstract][Full Text] [Related]
15. Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
Guillot E; Sermet I; Ferroni A; Chhun S; Pons G; Zahar JR; Jullien V
Pharmacotherapy; 2010 Dec; 30(12):1252-8. PubMed ID: 21114393
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.
Maciá MD; Borrell N; Segura M; Gómez C; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2006 Mar; 50(3):975-83. PubMed ID: 16495260
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.
Yadav R; Bulitta JB; Wang J; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993331
[TBL] [Abstract][Full Text] [Related]
18. Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin.
Bendig JW; Kyle PW; Giangrande PL; Samson DM; Azadian BS
J R Soc Med; 1987 May; 80(5):316-7. PubMed ID: 3112380
[No Abstract] [Full Text] [Related]
19. In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin.
Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O
BMC Infect Dis; 2010 Jun; 10():153. PubMed ID: 20525378
[TBL] [Abstract][Full Text] [Related]
20. Are ciprofloxacin dosage regimens adequate for antimicrobial efficacy and prevention of resistance? Pseudomonas aeruginosa bloodstream infection in elderly patients as a simulation case study.
Cazaubon Y; Bourguignon L; Goutelle S; Martin O; Maire P; Ducher M
Fundam Clin Pharmacol; 2015 Dec; 29(6):615-24. PubMed ID: 26406268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
